Sort
130,381 grants matching “hiv”
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR HIV/AIDS
$845,162Miriam Hospital · U01 · FY2001 · AI
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$845,032Kathleen Powis · Massachusetts General Hospital · R01 · FY2023 · AI
EXPANSION OF HIV VCT, PMTCT STUDIES AND HIV SURVEILLANCE IN SOUTH AFRICA
$845,000Nomonde Xundu · South Africa Department Of Health · U62 · FY2007 · PS
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
$844,990Connie L Celum · University Of Washington · R01 · FY2010 · AI
T Cell Dynamics In SIV-infected Macaques
$844,942Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
SUBSTANCE ABUSE MEDICATIONS DEVELOPMENT RESEARCH CENTER
$844,883University Of Texas Hlth Sci Ctr Houston · P50 · FY2000 · DA
BLOCKING INFECTIOUS ENTRY OF STD PATHOGENS
$844,875Johns Hopkins University · P01 · FY2000 · AI
HIV Risks and Transitions to Injection among Non-IDUs
$844,668Universidad Central Del Caribe · R01 · FY2004 · DA
Inflammation, BBB disruption, and Reward Function in the Pathogenesis of Depression among PWH
$844,635Vilma Gabbay · Albert Einstein College Of Medicine · R01 · FY2022 · MH
GH11-1152, S. AFRICA: REDUCING NEW HIV INFEC IN BONJANALA PLATINUM , N.W. PROV
$844,622Scott Barnhart · University Of Washington · U2G · FY2016 · GH
Rhesus Macaque Model of Accelerated Aging
$844,589Elizabeth Schmidt Didier · Tulane University Of Louisiana · R56 · FY2016 · AG
eCD4-Ig for preventing and treating obstetric HIV infection
$844,588Mauricio De Aguiar Martins · Scripps Florida · R01 · FY2020 · HD
Development of natural product inhibitors of Nef for clearance of HIV reservoirs
$844,572David H Sherman · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Targeting PD-1 Pathway for Functional Cure of AIDS
$844,556Rama Rao Amara · Emory University · R37 · FY2017 · AI
Reducing Intersectional Stigma among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP
$844,524Jae M. Sevelius · University Of California, San Francisco · R01 · FY2021 · MH
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$844,491Afamefuna Okoye · Oregon Health & Science University · R01 · FY2021 · AI
Test and Linkage to Care (TLC_IDU) Kenya
$844,462Ann E Kurth · New York University · R01 · FY2012 · DA
Macrophages in the pathogenesis of AIDS
$844,417Marcelo J Kuroda · Tulane University Of Louisiana · R01 · FY2012 · AI
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors
$844,362Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Determinants of HIV latency in CD4+ T lymphocytes
$844,304Viviana A Simon · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)
$844,255Matthias Egger · Universitat Bern · R01 · FY2024 · AI
Structural Racism and Discrimination in Older Men's Health Inequities
$844,201Jesus Ramirez-Valles · University Of California, San Francisco · R01 · FY2022 · AG
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$844,173Owen W. Pornillos · University Of Utah · U54 · FY2024 · AI
NIDA Epidemiology Training Program
$844,138Brion S Maher · Johns Hopkins University · T32 · FY2019 · DA
Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya
$844,134Sarah Finocchario Kessler · University Of Kansas Medical Center · R01 · FY2017 · HD